4th Quarter - Report — PARDES BIOSCIENCES, INC. for PARDES BIOSCIENCES, INC. (2022)

Firm

PARDES BIOSCIENCES, INC.

Client

PARDES BIOSCIENCES, INC.

Income

—

Expenses

$120,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

COVID Oral antivirals

Lobbyist	Covered position, as disclosed
JOHN MARTIN	Principal Associate Commissioner, FDA Legislative Affairs, Sen. Tom Cotton

Contacted: Office of Science & Technology Policy (OSTP); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Pharmacy PHA

Covid Oral Anti Virals

Lobbyist	Covered position, as disclosed
JOHN MARTIN	Principal Associate Commissioner, FDA Legislative Affairs, Sen. Tom Cotton

Contacted: Centers For Medicare and Medicaid Services (CMS); Office of Science & Technology Policy (OSTP); SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

COVID Oral Antivirals

Lobbyist	Covered position, as disclosed
JOHN MARTIN	Principal Associate Commissioner, FDA Legislative Affairs, Sen. Tom Cotton

Contacted: Office of Science & Technology Policy (OSTP); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

COVID Oral Antivirals

Lobbyist	Covered position, as disclosed
JOHN MARTIN	Principal Associate Commissioner, FDA Legislative Affairs, Sen. Tom Cotton

Contacted: Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.